TUFIN SOFTWARE TECHNOLOGIES (TUFN)

IL0011571556 - Common Stock

12.94  +0.32 (+2.54%)

After market: 12.94 0 (0%)

Fundamental Rating

2

Taking everything into account, TUFN scores 2 out of 10 in our fundamental rating. TUFN was compared to 277 industry peers in the Software industry. While TUFN seems to be doing ok healthwise, there are quite some concerns on its profitability. TUFN is valied quite expensively at the moment, while it does show a decent growth rate.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

TUFN had negative earnings in the past year.
In the past 5 years TUFN always reported negative net income.
TUFN had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -31.42%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -35.02%
PM (TTM) -37.3%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

5

2. Health

2.1 Basic Checks

TUFN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TUFN has been increased compared to 1 year ago.
TUFN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

TUFN has an Altman-Z score of 1.09. This is a bad value and indicates that TUFN is not financially healthy and even has some risk of bankruptcy.
There is no outstanding debt for TUFN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.09
ROIC/WACCN/A
WACC7.9%

2.3 Liquidity

A Current Ratio of 1.45 indicates that TUFN should not have too much problems paying its short term obligations.
A Quick Ratio of 1.45 indicates that TUFN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.45

More info and screens

4

3. Growth

3.1 Past

The earnings per share for TUFN have decreased strongly by -30.91% in the last year.
Looking at the last year, TUFN shows a quite strong growth in Revenue. The Revenue has grown by 15.21% in the last year.
TUFN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.52% yearly.
EPS 1Y (TTM)-30.91%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-4.55%
Revenue 1Y (TTM)15.21%
Revenue growth 3Y9.29%
Revenue growth 5Y14.52%
Revenue growth Q2Q14.64%

3.2 Future

TUFN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.69% yearly.
The Revenue is expected to grow by 12.09% on average over the next years. This is quite good.
EPS Next Y-8.19%
EPS Next 2Y2.43%
EPS Next 3Y0.7%
EPS Next 5Y-0.69%
Revenue Next Year14.45%
Revenue Next 2Y12.64%
Revenue Next 3Y11.91%
Revenue Next 5Y12.09%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TUFN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TUFN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -10.36

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.43%
EPS Next 3Y0.7%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TUFN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TUFIN SOFTWARE TECHNOLOGIES

NYSE:TUFN (8/24/2022, 7:04:00 PM)

After market: 12.94 0 (0%)

12.94

+0.32 (+2.54%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap490.70M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.42%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -35.02%
PM (TTM) -37.3%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.45
Quick Ratio 1.45
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-30.91%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-8.19%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.21%
Revenue growth 3Y9.29%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y